A systematic review and meta-analysis of psychiatric diseases in individuals with primary hyperhidrosis
- PMID: 39351777
- DOI: 10.1093/ced/llae389
A systematic review and meta-analysis of psychiatric diseases in individuals with primary hyperhidrosis
Abstract
Primary hyperhidrosis is associated with a substantial mental burden. In this study, the objective was to compare the occurrence of psychiatric diseases in individuals with and without primary hyperhidrosis by systematically reviewing the literature and conducting a meta-analysis. The PRISMA statement and the MOOSE checklist were employed. Cochrane Library, Embase and PubMed were searched. The risk of bias was determined by the Newcastle-Ottawa Scale. A random effects model was employed in the meta-analysis. Fifteen studies met the eligibility criteria, encompassing 50 429 participants with hyperhidrosis and 182 464 control participants. Hyperhidrosis was associated with increased odds of anxiety (odds ratio 3.5, 95% confidence interval 1.0-11.8) and depression (odds ratio 2.4, 95% confidence interval 1.4-4.0). Studies using outcome definitions for anxiety and depression and not included in the meta-analysis showed similar results. Studies reporting on other morbidities (i.e. body dysmorphic disorder, social phobia and stress) found a higher occurrence of these outcomes in the individuals with hyperhidrosis than in the control participants. Primary hyperhidrosis is associated with anxiety and depression. These results acknowledge the psychiatric burden that patients with primary hyperhidrosis experience.
© The Author(s) 2024. Published by Oxford University Press on behalf of British Association of Dermatologists. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Conflict of interest statement
Conflicts of interest: G.B.E.J. has received grants from AbbVie, LEO Foundation, Novartis, UCB, CSL Behring, Regeneron, Sanofi, Boehringer Ingelheim, Union Therapeutics, Toosonix and Henlez; has received honoraria from LEO Pharma and Incyte; is copyright holder of HISQOL; is Vice President for EHSF and the Chair of CHORD; and has stock in Henlez. M.A.S.H. and F.B. have no conflicts of interest to declare.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
